1. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy 
Thomas B. Casale, MD, Jonathan A. Bernstein, MD, Marcus Maurer, MD, Sarbjit S. Saini, MD, Benjamin Trzaskoma, MS, Hubert Chen, MD, Clive E. Grattan, MA, MD, FRCP, Ana Gimenéz-Arnau, MD, PhD, Allen P. Kaplan, MD, Karin Rosén, MD, PhD 
The Journal of Allergy and Clinical Immunology: In Practice 
Volume 3, Issue 5, Pages e1 (September 2015)
DOI: /j.jaip
Copyright © 2015 The Authors Terms and Conditions

2. Figure 1
Study designs. CIU, Chronic idiopathic urticaria; CSU, chronic spontaneous urticaria; LTRA, leukotriene receptor antagonist.
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, e1DOI: ( /j.jaip )
Copyright © 2015 The Authors Terms and Conditions

3. Figure 2
Proportion of responders by treatment group. *P < †P = UAS7, urticaria activity score over 7 d. Results for the GLACIAL study from Kaplan et al.11
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, e1DOI: ( /j.jaip )
Copyright © 2015 The Authors Terms and Conditions

4. Figure 3
Percent reductions in key endpoints from baseline to week 12. *P < †P = DLQI, Dermatology Life Quality Index; ISS, itch severity score; UAS7, urticaria activity score over 7 d.
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, e1DOI: ( /j.jaip )
Copyright © 2015 The Authors Terms and Conditions